Skip to content

Automated Non-Invasive Blood Pressure Study

Automated Non-Invasive Blood Pressure Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07790458
Enrollment
50
Registered
2026-08-27
Start date
2025-04-14
Completion date
2026-12-31
Last updated
2026-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Pressure, Blood Pressure Measurement

Brief summary

The purpose of the study is to design and implement methods to make an algorithm to estimate blood pressure changes.

Detailed description

Patient monitoring of blood pressure is essential for patient safety in hospitals. Automated non-invasive blood pressure (NIBP) uses data recorded with an SpO2 pulse oximeter to calculate a continuous estimate of blood pressure changes. The purpose of the study is to design and implement methods to make an algorithm to estimate blood pressure changes. This study will collect data for development of automated rules and evaluation of their performances in various clinical settings and to develop a larger clinical trial.

Interventions

None listed

Sponsors

GE Healthcare
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Able to provide written informed consent or have a LDR to provide written informed consent; 2. Are being cared for in OR, PACU or ICU and are expected to remain in the unit for the duration of the study procedure; 3. Have an invasive blood pressure measurement as a standard of care; AND 4. Are 18 years of age or older.

Exclusion criteria

1. Are known to be pregnant; 2. Are breastfeeding; 3. Are suffering from infection(s) that require isolation; OR 4. Have an external heart assistant device. 5. PI or caring physician decision due to subject health condition

Design outcomes

Primary

MeasureTime frameDescription
Primary Outcome MeasureUp to 24 hours after time of enrollmentThe primary outcome is to collect SpO2 data using Automated Non-Invasive Blood Pressure from subjects in ICU, OR and PACU environment using the investigational system. This data will be used for engineering development purposes.

Countries

Finland

Contacts

CONTACTErika Wilkman Principal Invastigator
erika.wilkman@hus.fi+35894711

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 28, 2026